The crystallographic structure of the FolB enzyme from (FolB), complexed with its inhibitor 8-mercaptoguanine (8-MG), was elucidated at a resolution of 1.95 Å. A novel series of S8-functionalized 8-MG derivatives were synthesised and evaluated as inhibitors of dihydroneopterin aldolase (DHNA, EC 4.1.2.25) activity of FolB. These compounds exhibited IC values in the submicromolar range. Evaluation of the activity for five compounds indicated their inhibition mode and inhibition constants. Molecular docking analyses were performed to determine the enzyme-inhibitor intermolecular interactions and ligand conformations upon complex formation. The inhibitory activities of all compounds against the H37Rv strain were evaluated. Compound exhibited a minimum inhibitory concentration in the micromolar range. Finally, Compound showed no apparent toxicity in both HepG2 and Vero cells. The findings presented herein will advance the quest for novel, specific inhibitors targeting FolB, an attractive molecular target for TB drug development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11328599PMC
http://dx.doi.org/10.1080/14756366.2024.2388207DOI Listing

Publication Analysis

Top Keywords

dihydroneopterin aldolase
8
crystal structure
4
structure dihydroneopterin
4
aldolase associated
4
associated 8-mercaptoguanine
4
8-mercaptoguanine development
4
development novel
4
novel s8-functionalized
4
s8-functionalized analogues
4
analogues inhibitors
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!